ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

HVO Hvivo Plc

28.25
0.75 (2.73%)
23 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hvivo Plc LSE:HVO London Ordinary Share GB00B9275X97 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.75 2.73% 28.25 28.00 28.50 28.25 27.50 27.50 826,104 13:23:49
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 48.48M -776k -0.0011 -256.82 190.71M
Hvivo Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker HVO. The last closing price for Hvivo was 27.50p. Over the last year, Hvivo shares have traded in a share price range of 14.15p to 31.00p.

Hvivo currently has 675,075,857 shares in issue. The market capitalisation of Hvivo is £190.71 million. Hvivo has a price to earnings ratio (PE ratio) of -256.82.

Hvivo Share Discussion Threads

Showing 4051 to 4072 of 9975 messages
Chat Pages: Latest  171  170  169  168  167  166  165  164  163  162  161  160  Older
DateSubjectAuthorDiscuss
25/1/2023
09:19
I suspect the new APAC region markets could well prove to be an outlier here with some positive sales occurring this year.
owenski
25/1/2023
09:15
Hardly surprising that its only reached 17p seeing as its short of serious investors. Most folk appear at 8am weekdays.

Give it time.

Its the old ebidta again - so many businesses scared of pbt. For all we know there’s a load of exceptionals - or not. Guessing game.

yump
25/1/2023
09:15
Finncap retain their 35p target price, and conclude:

"Order book and outlook. The orderbook stood at £76m at 31 December 2022, up 65% year-on-year, illustrating the strong delivery by management and increased levels of interest from its pharma/biotech customers in the use of Human Challenge Studies, for which hVIVO remains the undoubted global leader.

This excludes the £7.9m of new contract wins in January. With c.95% of FY 2023 revenues already contracted and visibility into 2024, double-digit growth in revenues provides further validation of the long-term sustainable growth model in the human challenge trial market, for which hVIVO is the world leader.

- Forecasts and valuation. We have adjusted FY 2022 to reflect the trading update, but leave FY 2023/24 unchanged for the time being. The current price implies the core business is now valued at 2023 EV/Sales and EV/EBITDA of 1.3x and 8.1x, dropping to 1.1x and 6.4x in 2024, respectively.

In our view, this neither reflects the estimated underlying growth, the defensive nature of the earnings, nor the strategic value of hVIVO."

rivaldo
25/1/2023
09:06
ZICO,
Of course it has! How do you think they managed to get the FY revenue figure after only having £18m at H1, it just shows how many trials they have concluded in the period which is due to the extra capacity, running concurrent trials to increase the through flow.
They are allowed to work through the order book, the deposit for a trial is a fraction of the revenue they get when they have concluded the trial. We will get plenty more trials contracted over the next few weeks and months and at much larger sums...

troutisout
25/1/2023
09:05
17p+is the new cheap level to buy in ..eyeing to hit 20p+sooner..gla
baldrick1
25/1/2023
09:00
Slow burning process for shorties..on a barbesue..without seasonings..
baldrick1
25/1/2023
08:46
Now buyers turn.. easy peasy
baldrick1
25/1/2023
08:44
Good to see the shorters getting burned yet again eh on HVO! Over the next few days and weeks after the presentations and interviews and number crunching by the fund managers I am confident we will be over 20p especially as a shareholder distribution has been announced for the first time. Growth & Income in a global market leader makes for a great investment long term!
adorling
25/1/2023
08:42
Chica and Sicko, you can now apologise to CF for all those lies and negative stories you have been peddling on here!
legaleagle66
25/1/2023
08:31
Zico and hamid ,,just buy back before increasing your losses
baldrick1
25/1/2023
08:29
Overall an excellent trading update but order backlog has decreased which is slightly concerning:

From 08/09/2022

"Going forward, I am highly encouraged by the Group's market-leading position, expanding addressable markets, and very substantial order book. With an order book of signed contracts worth c. GBP80m as at 1 September 2022,


From today's TU:

Strong contracted orderbook of GBP76m, up 65% year-on-year

Clearly this has reduced by £4m.

z1co
25/1/2023
08:26
Shares in issue 671 million Or 114 million Mcap at 17p
hamidahamida
25/1/2023
08:24
Let's push the shorties to buy back
baldrick1
25/1/2023
08:24
I thought we'd open 18p+
I actually got a chunk at 16.8p,so I'm pretty much square now.
Glad we have a good CEO now compared to his predecessor.

chica1
25/1/2023
08:23
Does anyone know how many shares in issue I make it 700 million or so
hamidahamida
25/1/2023
08:21
Let's get back up to 17p+ and upwards
baldrick1
25/1/2023
08:14
Pausing for the next leg up..
baldrick1
25/1/2023
08:05
I deserve to lavish myself for excessive high estimate..50pish..my diligent research on hvo paid off..
baldrick1
25/1/2023
08:02
Cracking update
hamidahamida
25/1/2023
08:02
That cash position - 28.4m - well ahead of what I was expecting, and the margins, superb >17%

CEO is delivering.

owenski
25/1/2023
08:00
Liberum have raised their target price to 25.1p (from 21.6p)....
rivaldo
25/1/2023
08:00
Lets get shorties up the share price by buying back big time..know who you are..
baldrick1
Chat Pages: Latest  171  170  169  168  167  166  165  164  163  162  161  160  Older

Your Recent History

Delayed Upgrade Clock